{"schema_version":"secwatch.filing_event.v1","accession":"0001628280-26-028852","form_type":"8-K","ticker":"NUTX","cik":"0001479681","company_name":"Nutex Health Inc.","filed_at":"2026-04-30T23:59:59+00:00","discovered_at":"2026-05-14T18:02:32.344434+00:00","generated_at":"2026-05-15T00:41:01.703868+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Nutex Health Q1 2026 net income $46.8M, diluted EPS $6.52, revenue $216.5M","bullets":["Revenue $216.5M (+2.2% YoY); hospital division revenue $207.6M.","Net income attributable to Nutex $46.8M (diluted EPS $6.52) vs $21.2M ($3.33) YoY.","Adjusted EBITDA $57.6M vs $72.8M YoY; operating cash flow $75.5M.","Board approved self-development of hospital facilities; plans 3-5 hospitals/year.","Cash $207.3M record high; long-term debt net $24.3M down from $29.2M."],"urls":{"canonical":"https://secwatch.observer/filing/0001628280-26-028852","json":"https://secwatch.observer/filing/0001628280-26-028852.json","markdown":"https://secwatch.observer/filing/0001628280-26-028852.md","text":"https://secwatch.observer/filing/0001628280-26-028852.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1479681/000162828026028852/0001628280-26-028852-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1479681/000162828026028852/nutx-20260430.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-15T00:41:01.703868+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"008cb286f23ed7238d4674f939f7e1d41d498746","claim":"Nutex Health Inc. reported first quarter ending March 31, 2026 results: revenue $216.5 million, net income $46.8 million, EPS $6.52.","evidence_excerpt":"division ), and a primary care-centric, risk-bearing physician network. Financial highlights for the three months ended March 31, 2026 : • Total revenue increased 2.2% to $216.5 million compared to $211.8 million for the same period in 2025, driven by 1.8% growth in hospital division revenue to $207.6 million from $203.9 million, while revenue at same hospitals,","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1479681/000162828026028852/0001628280-26-028852-index.htm","confidence":0.9,"family_label":"Earnings Releases","details":[{"label":"Period","value":"first quarter ending March 31, 2026"},{"label":"Revenue","value":"$216.5 million"},{"label":"Net income","value":"$46.8 million"},{"label":"EPS","value":"$6.52"},{"label":"Result","value":"reported results"}]}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}